• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCOVID-19 vaccines

Trump administration looks to claw back $11.4 billion in COVID funding from state and local health departments

By
Laura Ungar
Laura Ungar
and
The Associated Press
The Associated Press
Down Arrow Button Icon
By
Laura Ungar
Laura Ungar
and
The Associated Press
The Associated Press
Down Arrow Button Icon
March 26, 2025, 7:08 AM ET
A sign marks the entrance to the federal Centers for Disease Control and Prevention (CDC) in Atlanta, on Oct. 8, 2013.
A sign marks the entrance to the federal Centers for Disease Control and Prevention (CDC) in Atlanta, on Oct. 8, 2013.David Goldman—AP

Federal health officials said Tuesday they are pulling back $11.4 billion in COVID-19-related funds for state and local public health departments and other health organizations throughout the nation.

Recommended Video

“The COVID-19 pandemic is over, and HHS will no longer waste billions of taxpayer dollars responding to a non-existent pandemic that Americans moved on from years ago,” the U.S. Department of Health and Human Services said in a statement.

The statement said the Centers for Disease Control and Prevention expects to recover the money beginning 30 days after termination notices, which began being sent out on Monday.

Officials said the money was largely used for COVID-19 testing, vaccination and global projects as well as community health workers responding to COVID and a program established in 2021 to address COVID health disparities among high-risk and underserved patients, including those in minority populations. The move was first reported by NBC News.

Lori Freeman, CEO of the National Association of County & City Health Officials, said much of the funding was set to end soon anyway. “It’s ending in the next six months,” she said. “There’s no reason — why rescind it now? It’s just cruel and unusual behavior.”

In a related move, more than two dozen COVID-related research grants funded by the National Institutes of Health have been canceled. Earlier this month, the Trump administration shut down ordering from covidtest.gov, the site where Americans could have COVID-19 tests delivered to their mailboxes for no charge.

Although the COVID federal public health emergency has ended, the virus is still killing Americans: 458 people per week on average have died from COVID over the past four weeks, according to CDC data.

HHS wouldn’t provide many details about how the federal government expects to recover the money from what it called “impacted recipients.” But HHS spokesman Andrew Nixon said in an email: “The $11.4 billion is undisbursed funds remaining.”

Freeman said her understanding is that state health departments already had the COVID money.

“The funding was authorized by Congress, was appropriated by Congress, and it was out the door, basically, into the hands of the grantees” — states, she said, which decide how to distribute it locally.

Some of the COVID money is used to address other public health issues, Freeman added. For example, wastewater surveillance that began during COVID became important for detecting other diseases, too.

“It was being used in significant ways to track flu and patterns of new disease and emerging diseases — and even more recently with the measles outbreak,” Freeman said.

Under both the first Trump administration and the Biden administration, billions of dollars was allocated for COVID response through legislation, including a COVID relief bill and the American Rescue Plan Act.

At this point, it’s unclear exactly how health departments will be affected by the pullback of funds. But some were starting to look at what it might mean for them. In Washington state, for example, health officials were notified that more than $125 million in COVID-related funding has been immediately terminated. They are “assessing the impact” of the actions, they said.

In Los Angeles County, health officials said they could lose more than $80 million in core funding for vaccinations and other services. “Much of this funding supports disease surveillance, public health lab services, outbreak investigations, infection control activities at healthcare facilities and data transparency,” a department official wrote in an email.

Coins2Day Brainstorm AI returns to San Francisco Dec. 8–9 to convene the smartest people we know—technologists, entrepreneurs, Coins2Day Global 500 executives, investors, policymakers, and the brilliant minds in between—to explore and interrogate the most pressing questions about AI at another pivotal moment. Register here.
About the Authors
By Laura Ungar
See full bioRight Arrow Button Icon
By The Associated Press
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.